ALLIANCE PHARMA PLC — Remuneration Information 2013

Oct 24, 2013

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3657R

Alliance Pharma PLC

24 October 2013

For immediate release	24 October 2013

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

Share Options

Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, announces that on 23 October 2013 it awarded the following options over ordinary shares of the Company to certain Directors.

Name	Position	Number of share options awarded	Exercise price per share	Date of vesting	Percentage of issued ordinary share capital
Anthony Booley	Executive Director	400,000	35.75p	23 October 2018	0.16%
Peter Butterfield	Executive Director	400,000	35.75p	23 October 2018	0.16%
Richard Wright	Finance Director	400,000	35.75p	23 October 2018	0.16%

For further information:

### Alliance Pharma plc	### + 44 (0) 1249 466966
John Dawson, Chief Executive
Richard Wright, Finance Director
### Buchanan	### + 44 (0) 20 7466 5000
Mark Court
Numis Securities Limited	+ 44 (0) 20 7260 1000
Nominated Adviser: Michael Meade / Oliver Cardigan
Corporate Broking: David Poutney

Notes to editors:

About Alliance

Alliance, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has a strong track record of acquiring the rights to established niche products and owns or licenses the rights to more than 60 pharmaceutical products and continues to explore opportunities to expand the range.

Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSNKQDPABDDNKB